Authors:
Jones, HM
Travis, MJ
Mulligan, R
Bressan, RA
Visvikis, D
Gacinovic, S
Ell, PJ
Pilowsky, LS
Citation: Hm. Jones et al., In vivo 5-HT2A receptor blockade by quetiapine - An R91150 single photon emission tomography study, PSYCHOPHAR, 157(1), 2001, pp. 60-66
Authors:
Visvikis, D
Cheze-LeRest, C
Costa, DC
Bomanji, J
Gacinovic, S
Ell, PJ
Citation: D. Visvikis et al., Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [F-18]FDG PET, EUR J NUCL, 28(9), 2001, pp. 1326-1335
Authors:
Erlandsson, K
Visvikis, D
Waddington, WA
Jarritt, P
Citation: K. Erlandsson et al., Truncation reduction in fan-beam transmission scanning using the radon transform consistency conditions, IEEE NUCL S, 47(3), 2000, pp. 989-993
Authors:
Stephenson, CME
Bigliani, V
Jones, HM
Mulligan, RS
Acton, PD
Visvikis, D
Ell, PJ
Kerwin, RW
Pilowsky, LS
Citation: Cme. Stephenson et al., Striatal and extra-striatal D-2/D-3 dopamine receptor occupancy by quetiapine in vivo - [I-123]-epidepride single photon emission tomography (SPET) study, BR J PSYCHI, 177, 2000, pp. 408-415
Citation: D. Visvikis et al., Optimisation of noise equivalent count rates for brain and body FDG imaging using gamma camera PET, IEEE NUCL S, 46(3), 1999, pp. 624-630
Authors:
Bigliani, V
Mulligan, RS
Acton, PD
Visvikis, D
Ell, PJ
Stephenson, C
Kerwin, RW
Pilowsky, LS
Citation: V. Bigliani et al., In vivo occupancy of striatal and temporal cortical D-2/D-3 dopamine receptors by typical antipsychotic drugs - [I-123]-epidepride single photon emission tomography (SPET) study, BR J PSYCHI, 175, 1999, pp. 231-238